Bristol-Myers Squibb Gets FDA Approval To Market Abilify For Treatment Of Irritability Associated With Autistic Disorder - Quick Facts

Bristol-Myers Squibb Gets FDA Approval To Market Abilify For Treatment Of Irritability Associated With Autistic Disorder - Quick Facts
RTT News - 5 minutes ago
(RTTNews) - Bristol-Myers Squibb Co. (BMY: News ) said that it has received FDA approval to market Abilify for the treatment of irritability associated with autistic disorder in pediatric patients ...